{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:40:13Z","timestamp":1792615213458,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.hfc.2024.02.001","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T04:32:57Z","timestamp":1712205177000},"page":"249-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Amyloidosis and Amyloidogenesis"],"prefix":"10.1016","volume":"20","author":[{"given":"Marco","family":"Pozzan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Indennidate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guerino Giuseppe","family":"Varr\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Merlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Pagura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hfc.2024.02.001_bib1","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the american heart association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.hfc.2024.02.001_bib2","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.hfc.2024.02.001_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/13506129.2018.1549825","article-title":"Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"25","author":"Benson","year":"2018","journal-title":"Amyloid"},{"issue":"11P2","key":"10.1016\/j.hfc.2024.02.001_bib4","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.jcmg.2019.06.023","article-title":"Myocardial amyloidosis: the exemplar interstitial disease","volume":"12","author":"Fontana","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.hfc.2024.02.001_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071566","article-title":"Re-definition of the epidemiology of cardiac amyloidosis","volume":"10","author":"Rossi","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.hfc.2024.02.001_bib6","article-title":"\u201cAmyloid\u201d \u2014 historical aspects","author":"Tanskanen","year":"2013","journal-title":"Amyloidosis"},{"issue":"2","key":"10.1016\/j.hfc.2024.02.001_bib7","doi-asserted-by":"crossref","first-page":"a023572","DOI":"10.1101\/cshperspect.a023572","article-title":"The three-dimensional structures of amyloids","volume":"9","author":"Riek","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"22","key":"10.1016\/j.hfc.2024.02.001_bib8","doi-asserted-by":"crossref","first-page":"13970","DOI":"10.3390\/ijms232213970","article-title":"Amyloidogenesis: what do we know so far?","volume":"23","author":"Alraawi","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"18","key":"10.1016\/j.hfc.2024.02.001_bib9","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1093\/cvr\/cvac119","article-title":"Transthyretin cardiac amyloidosis","volume":"118","author":"Porcari","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.hfc.2024.02.001_bib10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00392-020-01799-3","article-title":"Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK)","volume":"110","author":"Yilmaz","year":"2021","journal-title":"Clin Res Cardiol"},{"issue":"17","key":"10.1016\/j.hfc.2024.02.001_bib11","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1001\/archinte.166.17.1805","article-title":"Amyloidosis and the heart","volume":"166","author":"Shah","year":"2006","journal-title":"Arch Intern Med"},{"issue":"21","key":"10.1016\/j.hfc.2024.02.001_bib12","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2014-12-618108","article-title":"Hereditary systemic immunoglobulin light-chain amyloidosis","volume":"125","author":"Benson","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hfc.2024.02.001_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-021-00236-z","article-title":"Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications","volume":"10","author":"Xu","year":"2021","journal-title":"Exp Hematol Oncol"},{"issue":"11","key":"10.1016\/j.hfc.2024.02.001_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116336","article-title":"Molecular Mechanism of Pathogenesis and Treatment Strategies for AL Amyloidosis","volume":"23","author":"Ikura","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.hfc.2024.02.001_bib15","doi-asserted-by":"crossref","DOI":"10.1182\/asheducation-2017.1.1","article-title":"AL amyloidosis: From molecular mechanisms to targeted therapies","volume":"2017","author":"Merlini","year":"2017","journal-title":"Hematology"},{"issue":"4","key":"10.1016\/j.hfc.2024.02.001_bib16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaccao.2022.08.007","article-title":"Low QRS voltages in cardiac amyloidosis: clinical correlates and prognostic value","volume":"4","author":"Cipriani","year":"2022","journal-title":"JACC CardioOncol"},{"issue":"19","key":"10.1016\/j.hfc.2024.02.001_bib17","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/01.CIR.0000068314.02595.B2","article-title":"Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis","volume":"107","author":"Palladini","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.hfc.2024.02.001_bib18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2459\/JCM.0000000000000349","article-title":"Different NT-proBNP circulating levels for different types of cardiac amyloidosis","volume":"17","author":"Perfetto","year":"2016","journal-title":"J\u00a0Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.hfc.2024.02.001_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-022-02414-6","article-title":"Global epidemiology of amyloid light-chain amyloidosis","volume":"17","author":"Kumar","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"10.1016\/j.hfc.2024.02.001_bib20","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2018016402","article-title":"Epidemiology of AL amyloidosis: A real-world study using US claims data","volume":"2","author":"Quock","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.hfc.2024.02.001_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1026440","article-title":"Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies","volume":"9","author":"Porcari","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.hfc.2024.02.001_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2013.10.026","article-title":"Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis","volume":"11","author":"Varr","year":"2014","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.hfc.2024.02.001_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacep.2020.01.004","article-title":"Management of arrhythmias in cardiac amyloidosis","volume":"6","author":"Giancaterino","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"10.1016\/j.hfc.2024.02.001_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(97)00267-2","article-title":"Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement","volume":"30","author":"Reisinger","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2024.02.001_bib25","article-title":"Guidelines on the diagnosis and management of AL amyloidosis","volume":"125","author":"Bird","year":"2004","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.hfc.2024.02.001_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000003170","article-title":"Kidney transplantation in systemic amyloidosis","volume":"104","author":"Angel-Korman","year":"2020","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.hfc.2024.02.001_bib27","first-page":"81","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the american college of cardiology solution set oversight committee","author":"Kittleson","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2024.02.001_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/S1665-2681(19)31450-4","article-title":"Primary hepatic amyloidosis: A mini literature review and five cases report","volume":"11","author":"Wang","year":"2012","journal-title":"Ann Hepatol"},{"issue":"4","key":"10.1016\/j.hfc.2024.02.001_bib29","article-title":"Clinical implications of gastrointestinal symptoms in systemic amyloidosis","volume":"30","author":"Yen","year":"2018","journal-title":"Neuro Gastroenterol Motil"},{"issue":"4","key":"10.1016\/j.hfc.2024.02.001_bib30","article-title":"Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: A single-center experience","volume":"30","author":"Lim","year":"2015","journal-title":"Kor J Intern Med"},{"issue":"6","key":"10.1016\/j.hfc.2024.02.001_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.hoc.2020.09.001","article-title":"Liver and gastrointestinal involvement: update","volume":"34","author":"Rosenzweig","year":"2020","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"10.1016\/j.hfc.2024.02.001_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2007.02.038","article-title":"Clinical recognition of AL type amyloidosis of the luminal gastrointestinal tract","volume":"5","author":"James","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.hfc.2024.02.001_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-021-00529-w","article-title":"Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study","volume":"11","author":"Staron","year":"2021","journal-title":"Blood Cancer J"},{"issue":"4","key":"10.1016\/j.hfc.2024.02.001_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaccao.2021.05.004","article-title":"two decades of cardiac amyloidosis: a Danish nationwide study","volume":"3","author":"Westin","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"12","key":"10.1016\/j.hfc.2024.02.001_bib35","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/ejhf.2532","article-title":"Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies","volume":"24","author":"Aimo","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.hfc.2024.02.001_bib36","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jaccao.2021.06.006","article-title":"ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review","volume":"3","author":"Griffin","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"3","key":"10.1016\/j.hfc.2024.02.001_bib37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/13506129.2017.1342235","article-title":"Changing epidemiology of AA amyloidosis: clinical observations over 25 years at a single national referral centre","volume":"24","author":"Lane","year":"2017","journal-title":"Amyloid"},{"issue":"38","key":"10.1016\/j.hfc.2024.02.001_bib38","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.hfc.2024.02.001_bib39","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.hfc.2024.02.001_bib40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/eurheartj\/ehz173","article-title":"Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"43","author":"Damy","year":"2022","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.hfc.2024.02.001_bib41","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/jnnp-2021-327909","article-title":"Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis","volume":"93","author":"Carroll","year":"2022","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.hfc.2024.02.001_bib42","doi-asserted-by":"crossref","DOI":"10.1080\/13506129.2019.1693359","article-title":"Causes of AA amyloidosis: a systematic review","volume":"27","author":"Brunger","year":"2020","journal-title":"Amyloid"},{"issue":"10","key":"10.1016\/j.hfc.2024.02.001_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/art.24735","article-title":"Susceptibility to AA amyloidosis in rheumatic diseases: A critical overview","volume":"61","author":"Obici","year":"2009","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.hfc.2024.02.001_bib44","doi-asserted-by":"crossref","DOI":"10.2147\/CLEP.S39981","article-title":"Systemic AA amyloidosis: epidemiology, diagnosis, and management","author":"Real de Asua","year":"2014","journal-title":"Clin Epidemiol"},{"issue":"23","key":"10.1016\/j.hfc.2024.02.001_bib45","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.hfc.2024.02.001_bib46","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ndt\/gfv318","article-title":"\u03b2 2 microglobulin amyloidosis: an update 30 years later","volume":"31","author":"Jadoul","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.hfc.2024.02.001_bib47","doi-asserted-by":"crossref","DOI":"10.34067\/KID.0004922020","article-title":"Beta-2 microglobulin amyloidosis: past, present, and future","volume":"1","author":"Portales-Castillo","year":"2020","journal-title":"Kidney360"},{"key":"10.1016\/j.hfc.2024.02.001_bib48","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.carpath.2019.05.002","article-title":"The pathology and changing epidemiology of dialysis-related cardiac beta-2 microglobulin amyloidosis","volume":"42","author":"Morris","year":"2019","journal-title":"Cardiovasc Pathol"},{"issue":"3","key":"10.1016\/j.hfc.2024.02.001_bib49","doi-asserted-by":"crossref","DOI":"10.3109\/10409238.2012.661401","article-title":"Gelsolin amyloidosis: Genetics, biochemistry, pathology and possible strategies for therapeutic intervention","volume":"47","author":"Solomon","year":"2012","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"3","key":"10.1016\/j.hfc.2024.02.001_bib50","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/13506129.2021.1911798","article-title":"Cardiac manifestations in Finnish gelsolin amyloidosis patients","volume":"28","author":"Mustonen","year":"2021","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.hfc.2024.02.001_bib51","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-020-1300-5","article-title":"Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study","volume":"15","author":"Schmidt","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.hfc.2024.02.001_bib52","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x2022e12284","article-title":"Renal amyloidosis: a new time for a complete diagnosis","volume":"55","author":"Feitosa","year":"2022","journal-title":"Braz J Med Biol Res"},{"issue":"26","key":"10.1016\/j.hfc.2024.02.001_bib53","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1056\/NEJMc0805012","article-title":"Cardiac amyloidosis with the E526V Mutation of the fibrinogen A \u03b1-chain","volume":"359","author":"Mourad","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hfc.2024.02.001_bib54","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1681\/ASN.2008060614","article-title":"Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A\u03b1-chain amyloidosis","volume":"20","author":"Gillmore","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.hfc.2024.02.001_bib55","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1681\/ASN.2006050460","article-title":"Amyloidosis-associated kidney disease","volume":"17","author":"Dember","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.hfc.2024.02.001_bib56","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1046\/j.1523-1755.1998.00770.x","article-title":"Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I","volume":"53","author":"Persey","year":"1998","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.hfc.2024.02.001_bib57","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s10157-011-0483-4","article-title":"Renal amyloidosis caused by apolipoprotein A-II without a genetic mutation in the coding sequence","volume":"15","author":"Morizane","year":"2011","journal-title":"Clin Exp Nephrol"},{"issue":"17","key":"10.1016\/j.hfc.2024.02.001_bib58","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.jacc.2017.02.047","article-title":"Apolipoprotein A-IV\u2013associated cardiac amyloidosis","volume":"69","author":"Bois","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2024.02.001_bib59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/13506129.2022.2070741","article-title":"The experience of hereditary apolipoprotein A-I amyloidosis at the UK National Amyloidosis Centre","volume":"29","author":"Cohen","year":"2022","journal-title":"Amyloid"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624000151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624000151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T12:25:47Z","timestamp":1717590347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713624000151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1551713624000151"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2024.02.001","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloidosis and Amyloidogenesis","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2024.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}